ArrePath
Signal active
Organization
Contact Information
Overview
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
About
Industries
Biotechnology, Health Care, Medical
Founded
2022
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ArrePath headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $240.0M in funding across 12 round(s). With a team of 11-50 employees, ArrePath is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - ArrePath, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
7
Lead Investors
0
Total Funding Amount
$20.0M
Details
1
ArrePath has raised a total of $20.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 20.0M |
Investors
ArrePath is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| AriMed Advisors | - | FUNDING ROUND - AriMed Advisors | 20.0M |
| Joshua Wachman | - | FUNDING ROUND - Joshua Wachman | 20.0M |
| ArrePath | - | FUNDING ROUND - ArrePath | 20.0M |
| Nor'easter Ventures | - | FUNDING ROUND - Nor'easter Ventures | 20.0M |
Recent Activity
There is no recent news or activity for this profile.